Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CardiaPill CP-101
- Development stage
- Preclinical
- Lead developer
- CardioPharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
CardiaPill CP-101 is a fixed-dose combination (polypill) small molecule therapeutic developed by CardioPharma for the prevention and treatment of cardiovascular disease (CVD). The formulation integrates three distinct pharmacological classes: a cholesterol-modifying agent, an antihypertensive agent, and an antiplatelet agent. This multi-mechanism approach is designed to simplify treatment regimens, thereby improving patient adherence and reducing the incidence of major adverse cardiovascular events (MACE). The program has completed retrospective clinical studies and analytical chemistry assessments, including shelf-life and pharmacokinetics studies, and is currently in the preclinical stage of development.
- Brand names
- CardiaPill
- Other names
- CardiaPill CP-101
02
Targets
HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)PGHS-1 (Prostaglandin G/H Synthase 1)ACE (Angiotensin Converting Enzyme)
Beyond the preview
Go deeper on CardiaPill CP-101.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CardiaPill CP-101.